Recent Press Releases

Teva Reaches Settlement in ProAir® HFA Patent Case

ERUSALEM, Jun 20, 2014 (BUSINESS WIRE) -- Teva Pharmaceutical Industries Ltd. announced that it has reached a settlement with Perrigo Pharmaceutical Co. and Catalent Pharma Solutions LLC with respect...

PAREXEL Cuts Clinical Trial Start-Up Time for Sponsors by Weeks with New Version of Industry-Leading Clinphone® RTSM Services

Latest RTSM technology features standardized study components for faster implementation and greater design flexibility BOSTON, MA – PAREXEL International (NASDAQ: PRXL), a leading global...

Merger of Simbec & ORION to Create a New International Full-Service CRO

Highlights: · Creation of an international CRO with complete service offering from Phase I to Phase IV post-authorisation studies · Appointment of a highly experienced...

Japan's CROee to Establish US-based Clinical Trial Recruitment Company with BBK Worldwide

SAN DIEGO and BOSTON -- DIA 2014 50th Annual Meeting -- BBK Worldwide, a leading clinical trial marketing firm, and CROee, the first consulting Japanese CRO specializing in patient recruitment, today...

Quintiles and Modern Marketing Concepts Collaborate to Launch Innovative Marketing Analytics Platform

RESEARCH TRIANGLE PARK, N.C. & BINGHAMTON, N.Y.--Quintiles and Modern Marketing Concepts (MMC, Inc.) today announced the launch of a new marketing analytics platform that enables Quintiles to...

BioClinica Acquires Blueprint Clinical, Inc.

NEWTOWN, Pa.--BioClinica®, Inc ., a leading provider of eClinical Solutions for the Pharmaceutical Industry, has announced the acquisition of Blueprint Clinical, a fast-growing company offering...

Parexel International Announces $150 Million Accelerated Share Repurchase Program

BOSTON, June 16, 2014 /PRNewswire/ -- PAREXEL International Corporation (Nasdaq: PRXL) announced today that it has entered into an Accelerated Share Repurchase (ASR) agreement with Goldman Sachs...

Actinium Engages a Leading CRO to Support Phase 3 Trial of Iomab-B

NEW YORK, Jun 16, 2014 (BUSINESS WIRE) -- Actinium Pharmaceuticals, Inc . ("Actinium" or "the Company"), a biopharmaceutical Company developing innovative targeted payload...

Cellectis and Accelera (Nerviano Medical Sciences Group) Sign an Agreement to Complete Preclinical Studies of Cellectis' Lead Product Candidate UCART19

Cellectis (Paris:ALCLS), a leader of allogeneic CAR T-cell therapies, and Accelera, the preclinical CRO (Contract Research Organisation) within the Nerviano Medical Sciences Group, recently signed...

PRA Advances to Become PRA Health Sciences

RALEIGH, N.C., June 16, 2014 -- PRA, a leading clinical research organization, today announced that it has changed its name to PRA Health Sciences (PRA). The name change to PRA Health Sciences is the...

NOVOTECH CRO ANNOUNCES MOU WITH KOREA DRUG DEVELOPMENT FUND (KDDF) AT DIA 2014

San Diego, CA | Novotech, Australia's largest clinical CRO with offices throughout Asia, has signed an MOU with the Korea Drug Development Fund (KDDF) to promote the development of the Korean...

Quintiles and American Physical Therapy Association Announce Plans to Develop New Outcomes Registry

RESEARCH TRIANGLE PARK, N.C. and ALEXANDRIA, Va. – Quintiles and the American Physical Therapy Association (APTA) today announced a new strategic collaboration to develop and implement the...

Veristat and Karyopharm Therapeutics Inc. Enter into Preferred Provider Agreement for Oncology and Novel Therapeutic Advancement

HOLLISTON, Mass.--Veristat, a full service Contract Research Organization, announced today that Karyopharm Therapeutics Inc. (Nasdaq:KPTI), a clinical-stage pharmaceutical company focused on the...

Oncobiologics launches Phase I Clinical Trial for ONS-3010 Biosimilar version of Humira®

CRANBURY, N.J. -- Oncobiologics, Inc. announced today that it has received approval to initiate a Phase I clinical trial in Europe for its first biosimilar molecule, ONS-3010, a highly biosimilar...

Leading Dermatology Contract Research Organization bioskin® Joins Medrio's Partner Program

NAPA, Calif. -- bioskin®, a leading dermatology CRO offering global clinical trial services, announces they have joined the Medrio partner program. Using Medrio's eClinical Software as a...

PAREXEL International Announces Stock Repurchase Program

BOSTON -- PAREXEL International Corporation (Nasdaq: PRXL) announced today that its Board of Directors has approved a stock repurchase program authorizing the repurchase of up to $150 million of the...

Biotech Consortium Launches KPI Therapeutics, Inc., a New Collaborative Initiative to Speed Drug Development and Improve Investor Outcomes

SEATTLE--Five biotech firms and private investors have announced the launch of KPI Therapeutics, Inc. with the aim of speeding advancement of novel, promising drug candidates that can improve the...

Celerion Establishes Business Presence in Singapore and Appoints Dr. Chew Lan Chong as Executive Director, Medical Research

Celerion is pleased to announce the expansion of a formal business presence in Singapore. Heading up the new operations in Singapore is Dr. Chew Lan Chong, MBBS, MRCS, MSc as Executive Director,...

TrialScope Acquires Deloitte Analytics LLC Assets Including PharmaCM Business

Creates industry-leading organization with proven solutions for ensuring compliance throughout the clinical trial process JERSEY CITY, N.J.-- TrialScope, a provider of clinical trial solutions and...

inVentiv Health and Aprecia Pharmaceuticals Form Innovative Partnership To Commercialize Aprecia's Unique Technology Platform

Aprecia is the first and only company offering the proprietary ZipDose® product platform that leverages three-dimensional printing (3DP) to create fast-melt pharmaceuticals inVentiv Health, the...